A Phase II Trial of Ganetespib: Efficacy and Safety in Patients (pts) with Metastatic Breast Cancer (MBC)

被引：3
|
作者：
Jhaveri, K. [1 ]
Chandarlapaty, S. [1 ]
Lake, D. [1 ]
Gilewski, T. [1 ]
Drullinsky, P. [1 ]
Sugarman, S. [1 ]
Wasserheit-Leiblich, C. [1 ]
Moynahan, M. E. [1 ]
D'Andrea, G. [1 ]
Haque, S. [1 ]
Patil, S. [1 ]
Bauman, L. [1 ]
Vukovic, V. [1 ]
El-Hariry, I. [1 ]
Hudis, C. [1 ]
Modi, S. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/0008-5472.SABCS11-P1-17-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-17-08
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase II trial of paclitaxel polyglumex (PPX) with capecitabine (C) for metastatic breast cancer (MBC)
    Northfelt, D. W.
    Allred, J. B.
    Liu, H.
    Hobday, T. J.
    Rodacker, M. W.
    Lyss, A. P.
    Fitch, T. R.
    Perez, E. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [32] A phase II study of pemetrexed and doxorubicin in patients with advanced or metastatic breast cancer (MBC)
    Blasinska-Morawiec, M.
    Martin, M.
    Salas, F.
    Falcon, S.
    Rolski, J.
    Ferrari, B. L.
    Guedez, N.
    Simms, L.
    Gulyas, S.
    Melemed, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [33] EFFICACY OF ERIBULIN IN ELDERLY PATIENTS (PTS) WITH METASTATIC BREAST CANCER (MBC) IN REAL CLINICAL PRACTICE IN RUSSIAN FEDERATION
    Vladimirova, Lubov
    Tikhanovskaya, Natalia
    Mitashok, Irina
    Storozhakova, Anna
    Gorbunova, Vera
    Manzyuk, Ludmila
    Zhukova, Ludmila
    Kovalenko, Elena
    Osipov, Mikhail
    Kolyadina, Irina
    Kostalanova, Yulia
    Bolotina, Larisa
    Semiglazova, Tatiana
    Tarasova, Anna
    Itkin, Ilia
    Raevskaya, Natalia
    Manikhas, Alexey
    Levchenko, Natalia
    Chubenko, Vyacheslav
    BREAST, 2019, 48 : S56 - S56
  • [34] Gemcitabine plus epirubicin plus taxol (GET) in metastatic breast cancer (MBC) patients (pts): A multicenter phase II study.
    Donati, S
    Gennari, A
    Conte, PF
    Cetto, GL
    Molino, A
    Crino, L
    Mazzoni, F
    Galligioni, E
    Mansutti, M
    ANNALS OF ONCOLOGY, 2000, 11 : 50 - 50
  • [35] Effect of race on the safety and efficacy outcomes of gemcitabine plus paclitaxel treated patients with metastatic breast cancer (MBC): Analyses from a phase III trial
    Wang, Y.
    Tai, D.
    Zhao, L.
    Gill, J.
    Obasaju, C. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [36] Phase II trial of temsirolimus in patients with metastatic breast cancer
    Gini F. Fleming
    Cynthia X. Ma
    Dezheng Huo
    Husain Sattar
    Maria Tretiakova
    L. Lin
    Olwen M. Hahn
    F. O. Olopade
    R. Nanda
    Philip C. Hoffman
    M. J. Naughton
    Timothy Pluard
    Suzanne D. Conzen
    Matthew J. Ellis
    Breast Cancer Research and Treatment, 2012, 136 : 355 - 363
  • [37] Frontline docetaxel (T) capecitabine M combination therapy in patients (pts) with metastatic breast cancer (MBC): A phase II study.
    Chun, JH
    Lee, HG
    Lee, ES
    Kim, E
    Oh, JH
    Ro, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 71S - 71S
  • [38] Phase II trial of temsirolimus in patients with metastatic breast cancer
    Fleming, Gini F.
    Ma, Cynthia X.
    Huo, Dezheng
    Sattar, Husain
    Tretiakova, Maria
    Lin, L.
    Hahn, Olwen M.
    Olopade, F. O.
    Nanda, R.
    Hoffman, Philip C.
    Naughton, M. J.
    Pluard, Timothy
    Conzen, Suzanne D.
    Ellis, Matthew J.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 136 (02) : 355 - 363
  • [39] Phase II trial of ixabepilone in patients with metastatic breast cancer (MBC) who are resistant to an anthracycline, a taxane and capecitabine.
    Thomas, E.
    Perez, E. A.
    Mukhopadhyay, P.
    Lerzo, G.
    Pivot, X.
    Bosserman, L. D.
    Mullaney, B.
    Vahdat, L.
    Hortobagyi, G. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 42S - 42S
  • [40] Phase I trial of vinorelbine and sorafenib in metastatic breast cancer (MBC)
    Luu, T. H.
    Frankel, P. H.
    Chung, C. T.
    Mortimer, J. E.
    Hurria, A.
    McNamra, M.
    Koehler, S.
    Somlo, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345